ImmunoConcEpT - UMR 5164: Dépôts récents
Voici les éléments 101-120 de 319
-
Characterization of the novel HLA-B*44:324:02 allele by sequencing-based typing
(HLA. vol. 102, n° 3, pp. 361-363, 2023-06)Article de revueLibre accès -
Facial involvement is reflective of patients’ global perception of vitiligo extent
(British Journal of Dermatology. vol. 189, n° 2, pp. 188-194, 2023-04)Article de revue -
Characterization of the novel HLA-C*03:552 allele by sequencing-based typing
(HLA. vol. 102, n° 2, pp. 237-238, 2023-04)Article de revue -
The role of platelets in immune-mediated inflammatory diseases
(Nature Reviews Immunology. vol. 23, n° 8, pp. 495-510, 2023-01)Article de revueLibre accès -
Characterization of the novel HLA-DRB1*01:140 allele by sequencing-based typing
(HLA. vol. 102, n° 1, pp. 102-104, 2023-02)Article de revueLibre accès -
Emergence of the fungal immune system
(iScience. vol. 26, n° 6, 2023-05)Article de revueLibre accès -
Protocole national de diagnostic et de soins pour la polychondrite chronique atrophiante
(Revue de Medecine Interne. vol. 44, n° 6, pp. 282-294, 2023-06)Article de revueLibre accès -
Characterization of the novel HLA-A*24:585 allele by sequencing-based typing
(HLA. vol. 102, n° 1, pp. 70-71, 2023-02)Article de revueLibre accès -
Characterization of the novel HLA-C*05:01:01:81Q allele by sequencing-based typing
(HLA. vol. 102, n° 1, pp. 93-95, 2023-02)Article de revueLibre accès -
Characterization of the novel HLA-B*51:370 allele by sequencing-based typing
(HLA. vol. 102, n° 1, pp. 84-86, 2023)Article de revueLibre accès -
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm
(Journal of the European Academy of Dermatology and Venereology. vol. 37, n° 11, pp. 2173-2184, 2023)Article de revueLibre accès -
Health literacy and topical corticosteroid adherence in parents of children with atopic dermatitis in France
(Journal of the European Academy of Dermatology and Venereology. vol. 37, n° 12, pp. e1417-e1419, 2023-07)Article de revueLibre accès -
Vitiligo patient population and disease burden in France: VIOLIN study results from the CONSTANCES cohort
(Journal of the European Academy of Dermatology and Venereology. vol. 37, n° 11, pp. 2249-2258, 2023-08)Article de revueLibre accès -
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review
(Journal of the European Academy of Dermatology and Venereology. vol. 37, n° 11, pp. 2231-2242, 2023-08-21)Article de revue -
Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype
(Journal of Allergy and Clinical Immunology. vol. 152, n° 5, pp. 1303-1311.e1, 2023-11)Article de revueLibre accès -
Efficacy and safety of the combination of steroid pulse therapy with methotrexate for vitiligo: A pilot retrospective case series
(Journal of the European Academy of Dermatology and Venereology. vol. 37, n° 11, pp. 2264-2266, 2023-08-10)Article de revue -
Characterization of the novel HLA-B*51:384 allele by sequencing-based typing
(HLA. vol. 102, n° 4, pp. 529-531, 2023-08-01)Article de revue -
Dosage des auto-anticorps : y a-t-il une place pour le doute ?
(Revue du Rhumatisme (Edition Francaise). vol. 90, n° 5, pp. 626-633, 2023)Article de revue -
Characterization of the novel HLA-DPA1*01:159 allele by sequencing-based typing
(HLA. vol. 102, n° 5, pp. 647-648, 2023)Article de revue -
Characterization of the novel HLA-DRB3*02:192 allele by sequencing-based typing
(HLA. vol. 102, n° 5, pp. 640-641, 2023-08)Article de revue